|
🐜
|
Clinical relevance of DPYD variants c.1679T>G, c.1236G>A/HapB3, and c.1601G>A as predictors of severe fluoropyrimidine-associated toxicity: a systematic review and meta-analysis of individual patient data.
23 auth.
D. Meulendijks,
L. Henricks,
G. Sonke,
M. Deenen,
T. K. Froehlich,
U. Amstutz,
C. Largiadèr,
B. Jennings,
A. Marinaki,
J. Sanderson,
...
Z. Kleibl,
P. Kleiblova,
M. Schwab,
U. Zanger,
C. Palles,
I. Tomlinson,
E. Gross,
A. V. van Kuilenburg,
C. Punt,
M. Koopman,
J. Beijnen,
A. Cats,
J. Schellens
|
8 |
2015 |
8
🐜
|
|
🐜
|
Cancer Risks Associated With Germline PALB2 Pathogenic Variants: An International Study of 524 Families.
129 auth.
Xin Yang,
Goska Leslie,
Alicja Doroszuk,
S. Schneider,
Jamie Allen,
Brennan Decker,
Brennan Decker,
Brennan Decker,
A. Dunning,
J. Redman,
J. Scarth,
Inga Plaskocinska,
C. Luccarini,
M. Shah,
K. Pooley,
...
L. Dorling,
Andrew J. Lee,
M. Adank,
J. Adlard,
K. Aittomäki,
I. Andrulis,
P. Ang,
J. Barwell,
J. Bernstein,
Kristie A. Bobolis,
Å. Borg,
C. Blomqvist,
K. Claes,
P. Concannon,
A. Cuggia,
A. Cuggia,
Julie O. Culver,
F. Damiola,
A. Pauw,
O. Díez,
Jill S. Dolinsky,
S. Domchek,
C. Engel,
D. Evans,
F. Fostira,
J. Garber,
L. Golmard,
E. Goode,
S. Gruber,
E. Hahnen,
Christopher R. Hake,
T. Heikkinen,
J. Hurley,
R. Janavicius,
Z. Kleibl,
P. Kleiblova,
I. Konstantopoulou,
A. Kvist,
H. LaDuca,
Ann S G Lee,
Ann S G Lee,
F. Lesueur,
E. Maher,
A. Mannermaa,
S. Manoukian,
R. McFarland,
W. Mckinnon,
A. Meindl,
K. Metcalfe,
N. A. Taib,
J. Moilanen,
K. Nathanson,
S. Neuhausen,
P. Ng,
T. Nguyen-Dumont,
T. Nguyen-Dumont,
S. Nielsen,
F. Obermair,
K. Offit,
O. Olopade,
L. Ottini,
Judith Penkert,
K. Pylkäs,
P. Radice,
S. Ramus,
S. Ramus,
V. Rudaitis,
L. Side,
Rachel Silva-Smith,
Valentina Silvestri,
A. Skytte,
T. Slavin,
J. Soukupová,
C. Tondini,
A. Trainer,
G. Unzeitig,
L. Usha,
Thomas V O Hansen,
J. Whitworth,
M. Wood,
C. Yip,
S. Yoon,
A. Yussuf,
G. Zogopoulos,
G. Zogopoulos,
D. Goldgar,
J. Hopper,
G. Chenevix-Trench,
P. Pharoah,
S. George,
J. Balmaña,
C. Houdayer,
C. Houdayer,
P. James,
Z. El-Haffaf,
H. Ehrencrona,
M. Janatová,
P. Peterlongo,
H. Nevanlinna,
R. Schmutzler,
Soo-Hwang Teo,
M. Robson,
T. Pal,
F. Couch,
J. Weitzel,
A. Elliott,
M. Southey,
M. Southey,
R. Winqvist,
D. Easton,
William D. Foulkes,
William D. Foulkes,
A. Antoniou,
M. Tischkowitz
|
8 |
2019 |
8
🐜
|
|
🦁
|
Gain-of-function mutations of PPM1D/Wip1 impair the p53-dependent G1 checkpoint
12 auth.
P. Kleiblova,
I. A. Shaltiel,
J. Benada,
J. Ševčík,
Soňa Pecháčková,
P. Pohlreich,
...
E. Voest,
P. Dundr,
J. Bartek,
Z. Kleibl,
R. Medema,
L. Macurek
|
7 |
2013 |
7
🦁
|
|
🐜
|
CHEK2 Germline Variants in Cancer Predisposition: Stalemate Rather than Checkmate
7 auth.
Lenka Stolarova,
P. Kleiblova,
M. Janatová,
J. Soukupová,
P. Zemánková,
L. Macurek,
...
Z. Kleibl
|
7 |
2020 |
7
🐜
|
|
🦁
|
Expression of adipokines and estrogen receptors in adipose tissue and placenta of patients with gestational diabetes mellitus
9 auth.
P. Kleiblova,
I. Dostálová,
M. Bártlová,
Z. Lacinová,
I. Ticha,
V. Krejčí,
...
D. Springer,
Z. Kleibl,
M. Haluzík
|
6 |
2010 |
6
🦁
|
|
🦁
|
Identification of deleterious germline CHEK2 mutations and their association with breast and ovarian cancer
29 auth.
P. Kleiblova,
Lenka Stolarova,
K. Křížová,
F. Lhota,
J. Hojný,
P. Zemánková,
O. Havranek,
M. Vočka,
Marta Černá,
Klára Lhotová,
M. Borecka,
M. Janatová,
J. Soukupová,
J. Ševčík,
M. Zimovjanova,
...
J. Kotlas,
A. Panczak,
K. Veselá,
J. Červenková,
M. Schneiderová,
M. Burocziova,
Kamila Burdová,
V. Stránecký,
L. Foretova,
E. Macháčková,
Spiros Tavandzis,
S. Kmoch,
L. Macurek,
Z. Kleibl
|
6 |
2019 |
6
🦁
|
|
🐜
|
Changes of endocrine function of adipose tissue in anorexia nervosa: comparison of circulating levels versus subcutaneous mRNA expression
8 auth.
R. Doležalová,
Z. Lacinová,
M. Dolinková,
P. Kleiblova,
D. Haluzíková,
D. Housa,
...
H. Papežová,
M. Haluzík
|
6 |
2007 |
6
🐜
|
|
🐜
|
Influence of dihydropyrimidine dehydrogenase gene (DPYD) coding sequence variants on the development of fluoropyrimidine-related toxicity in patients with high-grade toxicity and patients with excellent tolerance of fluoropyrimidine-based chemotherapy.
8 auth.
Z. Kleibl,
J. Fidlerová,
P. Kleiblova,
S. Kormunda,
M. Bilek,
K. Boušková,
...
J. Ševčík,
J. Novotný
|
6 |
2009 |
6
🐜
|
|
🐬
|
Inhibition of WIP1 phosphatase sensitizes breast cancer cells to genotoxic stress and to MDM2 antagonist nutlin-3
Soňa Pecháčková,
Kamila Burdová,
J. Benada,
P. Kleiblova,
G. Jenikova,
L. Macurek
|
6 |
2016 |
6
🐬
|
|
🐜
|
The PALB2 Gene Is a Strong Candidate for Clinical Testing in BRCA1- and BRCA2-Negative Hereditary Breast Cancer
10 auth.
M. Janatová,
Z. Kleibl,
J. Stribrna,
A. Panczak,
K. Veselá,
M. Zimovjanova,
...
P. Kleiblova,
P. Dundr,
J. Soukupová,
P. Pohlreich
|
5 |
2013 |
5
🐜
|
